H.I.G. BIOHEALTH PARTNERS
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
H.I.G. BIOHEALTH PARTNERS
Social Links:
Industry:
Biotechnology Life Science Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
214.855.2998
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Content Delivery Network Font Awesome Apache Euro JsDelivr
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-22 | Click Therapeutics | H.I.G. BioHealth Partners investment in Series B - Click Therapeutics | 52 M USD |
| 2020-05-27 | Arvelle Therapeutics | H.I.G. BioHealth Partners investment in Series A - Arvelle Therapeutics | 42.7 M USD |
| 2019-10-23 | Zerigo Health | H.I.G. BioHealth Partners investment in Series A - Zerigo Health | 18 M USD |
| 2019-07-16 | Exagen | H.I.G. BioHealth Partners investment in Venture Round - Exagen | 22.6 M USD |
| 2019-05-30 | Intact Vascular | H.I.G. BioHealth Partners investment in Series D - Intact Vascular | 25 M USD |
| 2019-02-18 | Arvelle Therapeutics | H.I.G. BioHealth Partners investment in Series A - Arvelle Therapeutics | 180 M CHF |
| 2018-06-15 | Iconic Therapeutics | H.I.G. BioHealth Partners investment in Venture Round - Iconic Therapeutics | 4.11 M USD |
| 2018-05-08 | Neurana Pharmaceuticals | H.I.G. BioHealth Partners investment in Series A - Neurana Pharmaceuticals | 60 M USD |
| 2018-04-16 | Intact Vascular | H.I.G. BioHealth Partners investment in Series C - Intact Vascular | 20 M USD |
| 2018-03-14 | On Target Laboratories | H.I.G. BioHealth Partners investment in Series B - On Target Laboratories | 4 M USD |
More informations about "H.I.G. BioHealth Partners"
Portfolio | H.I.G. Healthbridge - H.I.G. BioHealth Partners
H.I.G. Capital has invested in over 400 companies over our nearly 30 years. View investments in the H.I.G. BioHealth Partners portfolio » ... NJ, is a global technology-enabled clinical research …See details»
H.I.G. BioHealth Partners - Crunchbase
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical …See details»
H.I.G. BioHealth Partners - Investments, Portfolio & Company Exits
H.I.G. BioHealth Partners has made 3 diversity investments. Their most recent diversity investment was on Jul 16, 2019, when Exagen raised. obfuscated. obfuscated. Announced …See details»
About | H.I.G. BioHealth Partners
After making an investment, the H.I.G. BioHealth Partners team works closely with portfolio companies in key areas, including: Pre-clinical and clinical development strategy; …See details»
H.I.G. HealthBridge Partners investment portfolio - PitchBook
Jan 1, 2021 Founded in 2011, H.I.G. BioHealth Partners is a venture capital investment firm based in Miami, Florida. The firm seeks to invest in the pharmaceutical, biotechnology, …See details»
H.I.G. BioHealth Partners III: Fund Performance - PitchBook
Jan 1, 2020 H.I.G. BioHealth Partners III Limited Partners (1) The Southern Company Pension Plan is the sole limited partner of H.I.G. BioHealth Partners III. Its latest Original was on 01 …See details»
H.I.G. BioHealth Partners - Contacts, Employees, Board Members ...
H.I.G. BioHealth Partners has 5 current employee profiles, including Co-Founder Tony Tamer. Contacts. Edit Contacts Section. We're working on getting contact data for H.I.G. BioHealth …See details»
Our Team - H.I.G. BioHealth Partners
H.I.G. Capital’s team of more than 500 seasoned investment professionals brings substantial operating, strategic and financial management experience to all our investments. The …See details»
H.I.G. BioHealth Partners — 17 Portfolio companies, 26 …
Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations. This H.I.G. BioHealth Partners works on 11 percentage …See details»
Bruce Robertson Managing Director & Co-Head of HealthBridge
Prior to joining H.I.G., Bruce served most recently as Managing Director at Toucan Capital, a venture capital fund focusing on healthcare investments. While at Toucan, Bruce invested in …See details»
H.I.G. BioHealth Partners taps Watanabe as managing director
Mar 8, 2022 H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital, a leading global alternative investment firm with over $47 billion of equity capital under …See details»
H.I.G. BioHealth Partners - Funding, Financials, Valuation & Investors
H.I.G. BioHealth Partners has raised a total of $268M in a single venture fund, H.I.G. BioVentures Life Sciences Fund. This fund was announced on Apr 10, 2012 and raised a total of . …See details»
Biography of Bruce Robertson - The Official Board
May 22, 2024 At H.I.G. BioHealth Partners, Bruce Robertson has 2 colleagues including Alex Zisson (Managing Director), Gwen Watanabe (Life-Science Investment Affiliate)… At …See details»
Portfolio | H.I.G. BioHealth Partners - staging.higbio.com
H.I.G. Capital has invested in over 400 companies over our nearly 30 years. View investments in the H.I.G. BioHealth Partners portfolio » ... BioVectra is a leading contract development and …See details»
ESG | H.I.G. BioHealth Partners
H.I.G. BioHealth Partners is committed to prioritizing environmental, social and governance (ESG) factors in our investment activities. ... H.I.G. Capital. ESG Integration and Engagement. We …See details»
Team | H.I.G. BioHealth Partners
H.I.G. Capital’s team of more than 500 seasoned investment professionals brings substantial operating, strategic and financial management experience to all our investments. Alpha Team …See details»
Bruce Robertson - Managing Director @ H.I.G. BioHealth Partners ...
Prior to joining H.I.G., Bruce served most recently as Managing Director at Toucan Capital, an early-stage venture capital fund focusing on life science investments. While at Toucan, Bruce …See details»
News | H.I.G. BioHealth Partners
Search all news releases related to H.I.G. BioHealth Partners » MIAMI – April 1, 2024 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under …See details»
H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click ...
Oct 26, 2021 H.I.G. BioHealth Partners has co-led a $52 million Series B financing round for Click Therapeutics, a pioneer in the field of digital therapeutics.See details»